The Valley Desk

NCT03686124 · Interventional trial

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

Overall registry status Recruiting

Phase 1 · Phase 2

Conditions Cancer, Recurrent Cancer, Refractory Cancer, Solid Tumor, Adult

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov